| Safety of nanoparticles in medicine J Wolfram, M Zhu, Y Yang, J Shen, E Gentile, D Paolino, M Fresta, G Nie, ... Current drug targets 16 (14), 1671-1681, 2015 | 581 | 2015 |
| Multifunctional gold nanorods for siRNA gene silencing and photothermal therapy J Shen, HC Kim, C Mu, E Gentile, J Mai, J Wolfram, L Ji, M Ferrari, Z Mao, ... Advanced healthcare materials 3 (10), 1629-1637, 2014 | 111 | 2014 |
| Liposomal chemotherapeutics E Gentile, F Cilurzo, L Di Marzio, M Carafa, C Anna Ventura, J Wolfram, ... Future Oncology 9 (12), 1849-1859, 2013 | 83 | 2013 |
| Radium-223 treatment increases immune checkpoint expression in extracellular vesicles from the metastatic prostate cancer bone microenvironment I Vardaki, P Corn, E Gentile, JH Song, N Madan, A Hoang, N Parikh, ... Clinical Cancer Research 27 (11), 3253-3264, 2021 | 45 | 2021 |
| Multistage vector delivery of sulindac and silymarin for prevention of colon cancer MP Scavo, E Gentile, J Wolfram, J Gu, M Barone, M Evangelopoulos, ... Colloids and Surfaces B: Biointerfaces 136, 694-703, 2015 | 44 | 2015 |
| Serum microRNA‐150 predicts prognosis for early‐stage non‐small cell lung cancer and promotes tumor cell proliferation by targeting tumor suppressor gene SRCIN1 L Zhang, J Lin, Y Ye, T Oba, E Gentile, J Lian, J Wang, Y Zhao, J Gu, ... Clinical Pharmacology & Therapeutics 103 (6), 1061-1073, 2018 | 40 | 2018 |
| TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC) X Cao, Y Zhao, J Wang, B Dai, E Gentile, J Lin, X Pu, L Ji, S Wu, I Meraz, ... Oncotarget 8 (64), 107621, 2017 | 21 | 2017 |
| Long term stability evaluation of prostacyclin released from biomedical device through turbiscan lab expert C Celia, M Locatelli, F Cilurzo, D Cosco, E Gentile, D Scalise, M Carafa, ... Medicinal Chemistry 11 (4), 391-399, 2015 | 16 | 2015 |
| Cationic liquid crystalline nanoparticles for the delivery of synthetic RNAi-based therapeutics JARLJ Emanuela Gentile, Taro Oba, Jing Lin, Ruping Shao, Feng Meng, Xiaobo ... Oncotarget, 2017 | 10 | 2017 |
| A GATA2-CDC6 axis modulates androgen receptor blockade-induced senescence in prostate cancer I Mourkioti, A Polyzou, D Veroutis, G Theocharous, N Lagopati, E Gentile, ... Journal of Experimental & Clinical Cancer Research 42 (1), 187, 2023 | 8 | 2023 |
| Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate Cancer E Gentile, AW Hahn, JH Song, A Hoang, PDA Shepherd, ... Cancer Research Communications 3 (12), 2531-2543, 2023 | 1 | 2023 |
| Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone S Maksimovic, NC Boscolo, L La Posta, S Barrios, MJ Moussa, E Gentile, ... Cancer Research Communications 4 (10), 2621-2637, 2024 | | 2024 |
| Cationic liquid crystalline nanoparticles E Gentile, J Lin, JA Roth US Patent App. 16/620,090, 2020 | | 2020 |
| A novel cationic liquid crystalline nanoparticle for the delivery of synthetic RNAi-based therapeutics E Gentile, T Oba, J Lin, R Shao, F Meng, X Cao, D Cai, JA Roth, L Ji Cancer Research 76 (14_Supplement), 3906-3906, 2016 | | 2016 |
| Circulating biomarker miRNA-150 promotes tumor cell proliferation and progression by targeting SRC kinase signaling inhibitor 1 (SRCIN1) in non-small cell lung cancer J Lin, L Zhang, Y Ye, T Oba, E Gentile, E Gentile, J Wang, Y Zhao, J Gu, ... Cancer Research 76 (14_Supplement), 964-964, 2016 | | 2016 |
| Serum miR152 as a novel prognostic biomarker and potential tumor suppressor for early stage non-small cell lung cancer T Oba, Y Ye, L Zhang, J Lin, E Gentile, J Wang, Y Zhao, J Gu, I Wistuba, ... Cancer Research 76 (14_Supplement), 1115-1115, 2016 | | 2016 |
| Effect of TWEEN 80 and Poloxamer 188 on the physico-chemical properties of PLGA/Chitosan nanospheres encapsulating plasmidic DNA C Federico, D Cosco, R Molinaro, D Paolino, E Gentile, P Tassone, ... XIII Summer School per la Formazione Avanzata in Discipline Tecnologico …, 2013 | | 2013 |
| Smart Nanomedicine Based on Vesicular Structure for Efficient Therapeutic Approaches D Paolino, C Celia, D Cosco, F Cilurzo, E Gentile, L Di Marzio, M Fresta NanotechITALY2013, 2013 | | 2013 |
| Ufasomes like new potential devices in fuctional foods and nutraceuticals E Trapasso, E Gentile, F Cilurzo, V Morittu, D Britti, M Fresta, D Paolino Chem4Life, 2011 | | 2011 |
| 9-cis-Retinoic Acid-loaded PEG-coated PLGA-nanoparticles: characterization and in vitro evaluation of pharmacological activity R Molinaro, D Cosco, E Gentile, D Scalise, M Fresta, D Paolino 3rd PharmSciFair, 2011 | | 2011 |
